130 related articles for article (PubMed ID: 8209501)
1. [The principles of administering drug and non-drug treatment methods in peptic ulcer].
Perederiĭ VG; Bychkova NG; Petrov AV; Seliuk MN; Dogotar' VB; Iurchenko ES; Tkach SM; Shvets GL; Vysotiuk LA; Marusanich BN
Lik Sprava; 1993; (5-6):58-61. PubMed ID: 8209501
[TBL] [Abstract][Full Text] [Related]
2. [Drug and non-drug immunocorrection in peptic ulcer].
Petrov AV; Bychkova NG; Perederiĭ VG; Dogotar' VB; Vysotiuk LA
Lik Sprava; 1993 Apr; (4):100-2. PubMed ID: 8209427
[TBL] [Abstract][Full Text] [Related]
3. [The immunological aspects of the antibacterial therapy of peptic ulcer patients].
Bychkova NG; Petrov AV; Perederiĭ VG; Iurchenko ES
Lik Sprava; 1993; (10-12):79-81. PubMed ID: 8030316
[TBL] [Abstract][Full Text] [Related]
4. [The effect of superhigh-frequency electromagnetic radiation on the course of Helicobacter pylori-associated peptic ulcer].
Starodub IeM; Samohal's'ka OIe; Markiv IM; Luchanko PI
Lik Sprava; 1994 Jan; (1):85-7. PubMed ID: 8067031
[TBL] [Abstract][Full Text] [Related]
5. [An SHF electromagnetic field (460 MHz) combined with the preparation Tribimol in treating duodenal peptic ulcer associated with Helicobacter pylori].
Filimonov RM; Korolev IuN; Konicheva ER
Vopr Kurortol Fizioter Lech Fiz Kult; 1998; (1):23-5. PubMed ID: 9560998
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
Cherian PT; Cherian S; Singh P
Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640
[TBL] [Abstract][Full Text] [Related]
7. [The drug prophylaxis of peptic ulcer exacerbations].
Grigor'ev PIa; Iakovenko EP; Agafonova NA; Prianishnikova AS; Soluianova IP; Iakovenko AV; Vasil'ev IV; Agrba VZ; Stepanov AV; Kolodkin AM
Ter Arkh; 1995; 67(2):26-9. PubMed ID: 7725253
[TBL] [Abstract][Full Text] [Related]
8. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
Leodolter A; Peitz U; Malfertheiner P
Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
[TBL] [Abstract][Full Text] [Related]
9. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA
Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
[TBL] [Abstract][Full Text] [Related]
10. [Combined therapy of duodenal ulcer associated with Helicobacter pylori with electromagnetic decimeter waves and colloidal bismuth subcitrate].
Filimonov RM; Korolev IuN; Kochineva ER
Vopr Kurortol Fizioter Lech Fiz Kult; 1993; (6):19-22. PubMed ID: 8154113
[No Abstract] [Full Text] [Related]
11. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome.
Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M
Aliment Pharmacol Ther; 2005 Apr; 21(8):1047-53. PubMed ID: 15813841
[TBL] [Abstract][Full Text] [Related]
13. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.
Chiba N; Lahaie R; Fedorak RN; Bailey R; Veldhuyzen van Zanten SJ; Bernucci B
Can Fam Physician; 1998 Jul; 44():1481-8. PubMed ID: 9678277
[TBL] [Abstract][Full Text] [Related]
15. Peptic ulcer recurrence and Helicobacter pylori: evidence from Japan.
Tsuji S; Kawano S
J Gastroenterol; 2003; 38(4):410-1. PubMed ID: 12743786
[No Abstract] [Full Text] [Related]
16. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
[TBL] [Abstract][Full Text] [Related]
17. Development of duodenal ulcer concomitant with successful Helicobacter pylori eradication.
Pohle T; Hilker E; Domschke W
Z Gastroenterol; 1997 Jul; 35(7):563-5. PubMed ID: 9273989
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725
[TBL] [Abstract][Full Text] [Related]
19. [The treatment characteristics of patients with peptic ulcer infected with Helicobacter pylori].
Kharchenko NV
Lik Sprava; 1999 Mar; (2):70-4. PubMed ID: 10424047
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
